Boston, MA, United States of America

Rolf I Carlson

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Waban, MA (US) (2004 - 2006)
  • Boston, MA (US) (2004 - 2024)

Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Rolf I Carlson: Innovator in Medical Antibodies

Introduction

Rolf I Carlson is a prominent inventor based in Boston, MA (US), known for his significant contributions to the field of medical research. He holds a total of 9 patents, showcasing his innovative approach to addressing complex health issues.

Latest Patents

Among his latest patents are the Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). These patents focus on antibodies that bind to human chitinase-3-like protein 1 (CHI3L1) and their applications in detecting and treating these liver conditions. The antibodies are particularly useful in managing complications that arise from untreated progression, such as liver cirrhosis and hepatocellular carcinoma.

Career Highlights

Rolf I Carlson has had a distinguished career, working with notable institutions such as Rhode Island Hospital and Geistlich Pharma AG. His work has significantly advanced the understanding and treatment of liver diseases, making a lasting impact in the medical community.

Collaborations

Throughout his career, Rolf has collaborated with esteemed colleagues, including Jack Raymond Wands and Suzanne M De La Monte. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Rolf I Carlson's contributions to medical research, particularly in the development of antibodies for liver disease treatment, highlight his role as a leading inventor in the field. His work continues to influence advancements in healthcare and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…